ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, providing promising progress across different health-related and industrial applications. With its structural similarity to The natural way derived human serum albumin, OsrHSA gives a safer, more reliable choice for therapeutic use,